Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 302

1.

Initial Skin Cancer Screening for Solid Organ Transplant Recipients in the United States: Delphi Method Development of Expert Consensus Guidelines.

Crow LD, Jambusaria-Pahlajani A, Chung CL, Baran DA, Lowenstein SE, Abdelmalek M, Ahmed RL, Anadkat MJ, Arcasoy SM, Berg D, Bibee KP, Billingsley E, Black WH, Blalock TW, Bleicher M, Brennan DC, Brodland DG, Brown MR, Carroll BT, Carucci JA, Chang TW, Chaux G, Cusack CA, Dilling DF, Doyle A, Emtiazjoo AM, Ferguson NH, Fosko SW, Fox MC, Goral S, Gray AL, Griffin JR, Hachem RR, Hall SA, Hanlon AM, Hayes D Jr, Hickey GW, Holtz J, Hopkins RS, Hu J, Huang CC, Jiang SIB, Kapnadak SG, Kraus ES, Lease ED, Leca N, Lee JC, Leitenberger JJ, Lim MA, Longo MI, Malik SM, Mallea JM, Menter A, Myers SA, Neuburg M, Nijhawan RI, Norman DJ, Otley CC, Paek SY, Parulekar AD, Patel MJ, Patel VA, Patton TJ, Pugliano-Mauro M, Ranganna K, Ravichandran AK, Redenius R, Roll GR, Samie FH, Shin T, Singer JP, Singh P, Soon SL, Soriano T, Squires R, Stasko T, Stein JA, Taler SJ, Terrault NA, Thomas CP, Tokman S, Tomic R, Twigg AR, Wigger MA, Zeitouni NC, Arron ST.

Transpl Int. 2019 Sep 10. doi: 10.1111/tri.13520. [Epub ahead of print]

PMID:
31502728
2.

Risk of ESKD in Older Live Kidney Donors with Hypertension.

Al Ammary F, Luo X, Muzaale AD, Massie AB, Crews DC, Waldram MM, Qadi MA, Garonzik-Wang J, Henderson ML, Brennan DC, Wiseman AC, Lindrooth RC, Snyder JJ, Coresh J, Segev DL.

Clin J Am Soc Nephrol. 2019 Jul 5;14(7):1048-1055. doi: 10.2215/CJN.14031118. Epub 2019 Jun 25.

PMID:
31239252
3.

Physical Impairment and Access to Kidney Transplantation.

Haugen CE, Agoons D, Chu NM, Liyanage L, Long J, Desai NM, Norman SP, Brennan DC, Segev DL, McAdams-DeMarco M.

Transplantation. 2019 Apr 25. doi: 10.1097/TP.0000000000002778. [Epub ahead of print]

PMID:
31033648
4.

WNT pathway signaling is associated with microvascular injury and predicts kidney transplant failure.

Seifert ME, Gaut JP, Guo B, Jain S, Malone AF, Geraghty F, Della Manna DL, Yang ES, Yi N, Brennan DC, Mannon RB.

Am J Transplant. 2019 Mar 27. doi: 10.1111/ajt.15372. [Epub ahead of print]

PMID:
30916889
5.

The changing landscape of live kidney donation in the United States from 2005 to 2017.

Al Ammary F, Bowring MG, Massie AB, Yu S, Waldram MM, Garonzik-Wang J, Thomas AG, Holscher CM, Qadi MA, Henderson ML, Wiseman AC, Gralla J, Brennan DC, Segev DL, Muzaale AD.

Am J Transplant. 2019 Sep;19(9):2614-2621. doi: 10.1111/ajt.15368. Epub 2019 May 3.

PMID:
30903733
6.

Frailty and Access to Kidney Transplantation.

Haugen CE, Chu NM, Ying H, Warsame F, Holscher CM, Desai NM, Jones MR, Norman SP, Brennan DC, Garonzik-Wang J, Walston JD, Bingaman AW, Segev DL, McAdams-DeMarco M.

Clin J Am Soc Nephrol. 2019 Apr 5;14(4):576-582. doi: 10.2215/CJN.12921118. Epub 2019 Mar 19.

PMID:
30890577
7.

Rabbit anti-thymocyte globulin for the prevention of acute rejection in kidney transplantation.

Alloway RR, Woodle ES, Abramowicz D, Segev DL, Castan R, Ilsley JN, Jeschke K, Somerville KT, Brennan DC.

Am J Transplant. 2019 Aug;19(8):2252-2261. doi: 10.1111/ajt.15342. Epub 2019 Apr 3.

PMID:
30838775
8.

Cannabis Dependence or Abuse in Kidney Transplantation: Implications for Posttransplant Outcomes.

Alhamad T, Koraishy FM, Lam NN, Katari S, Naik AS, Schnitzler MA, Xiao H, Axelrod DA, Dharnidharka VR, Randall H, Ouseph R, Segev DL, Brennan DC, Devraj R, Kasiske BL, Lentine KL.

Transplantation. 2019 Feb 4. doi: 10.1097/TP.0000000000002599. [Epub ahead of print]

PMID:
30747847
9.

The landscape of international living kidney donation in the United States.

Al Ammary F, Thomas AG, Massie AB, Muzaale AD, Shaffer AA, Koons B, Qadi MA, Crews DC, Garonzik-Wang J, Fang H, Brennan DC, Lentine KL, Segev DL, Henderson ML.

Am J Transplant. 2019 Jul;19(7):2009-2019. doi: 10.1111/ajt.15256. Epub 2019 Feb 8.

PMID:
30615253
10.

Renal Function, Albuminuria, and the Risk of Cardiovascular Events After Kidney Transplantation.

Lam NN, Klarenbach S, Quinn RR, Hemmelgarn B, Tonelli M, Ye F, Ravani P, Bello AK, Brennan DC, Lentine KL.

Transplant Direct. 2018 Sep 6;4(10):e389. doi: 10.1097/TXD.0000000000000828. eCollection 2018 Oct.

11.

The national landscape of deceased donor kidney transplantation for the highly sensitized: Transplant rates, waitlist mortality, and posttransplant survival under KAS.

Jackson KR, Covarrubias K, Holscher CM, Luo X, Chen J, Massie AB, Desai N, Brennan DC, Segev DL, Garonzik-Wang J.

Am J Transplant. 2019 Apr;19(4):1129-1138. doi: 10.1111/ajt.15149. Epub 2018 Nov 26.

PMID:
30372592
12.

Everyday People Sing a Simple Song: Establishing a Core Outcome for Life Participation.

Aala A, Brennan DC.

Transplantation. 2019 Jun;103(6):1078-1079. doi: 10.1097/TP.0000000000002477. No abstract available.

PMID:
30300281
13.

Influence of pretransplant midodrine use on outcomes after kidney transplantation.

Pottebaum AA, Hagopian JC, Brennan DC, Gharabagi A, Horwedel TA.

Clin Transplant. 2018 Sep;32(9):e13366. doi: 10.1111/ctr.13366. Epub 2018 Aug 20.

PMID:
30076650
14.

Who can tolerate a marginal kidney? Predicting survival after deceased donor kidney transplant by donor-recipient combination.

Bae S, Massie AB, Thomas AG, Bahn G, Luo X, Jackson KR, Ottmann SE, Brennan DC, Desai NM, Coresh J, Segev DL, Garonzik Wang JM.

Am J Transplant. 2019 Feb;19(2):425-433. doi: 10.1111/ajt.14978. Epub 2018 Jul 14.

PMID:
29935051
15.

ACTH Gel in Resistant Focal Segmental Glomerulosclerosis After Kidney Transplantation.

Alhamad T, Manllo Dieck J, Younus U, Matar D, Alasfar S, Vujjini V, Wall D, Kanawati B, Reiser J, Brennan DC, Alachkar N.

Transplantation. 2019 Jan;103(1):202-209. doi: 10.1097/TP.0000000000002320.

PMID:
29894413
16.

Transformation in Immunosuppression: Are We Ready for it?

Aala A, Brennan DC.

J Am Soc Nephrol. 2018 Jul;29(7):1791-1792. doi: 10.1681/ASN.2018050491. Epub 2018 Jun 8. No abstract available.

17.

Incidence, Risk Factors, and Sequelae of Post-kidney Transplant Delirium.

Haugen CE, Mountford A, Warsame F, Berkowitz R, Bae S, Thomas AG, Brown CH 4th, Brennan DC, Neufeld KJ, Carlson MC, Segev DL, McAdams-DeMarco M.

J Am Soc Nephrol. 2018 Jun;29(6):1752-1759. doi: 10.1681/ASN.2018010064. Epub 2018 Apr 23.

18.

Cytomegalovirus: A Guide for the Perplexed.

Santos CAQ, Brennan DC.

Transplantation. 2018 Jun;102(6):898-899. doi: 10.1097/TP.0000000000002203. No abstract available.

PMID:
29677079
19.

Prescription opioid use before and after kidney transplant: Implications for posttransplant outcomes.

Lentine KL, Lam NN, Naik AS, Axelrod DA, Zhang Z, Dharnidharka VR, Hess GP, Segev DL, Ouseph R, Randall H, Alhamad T, Devraj R, Gadi R, Kasiske BL, Brennan DC, Schnitzler MA.

Am J Transplant. 2018 Dec;18(12):2987-2999. doi: 10.1111/ajt.14714. Epub 2018 Apr 17.

PMID:
29498196
20.

Results of ASERTAA, a Randomized Prospective Crossover Pharmacogenetic Study of Immediate-Release Versus Extended-Release Tacrolimus in African American Kidney Transplant Recipients.

Trofe-Clark J, Brennan DC, West-Thielke P, Milone MC, Lim MA, Neubauer R, Nigro V, Bloom RD.

Am J Kidney Dis. 2018 Mar;71(3):315-326. doi: 10.1053/j.ajkd.2017.07.018. Epub 2017 Nov 20.

21.

Center practice drives variation in choice of US kidney transplant induction therapy: a retrospective analysis of contemporary practice.

Dharnidharka VR, Naik AS, Axelrod DA, Schnitzler MA, Zhang Z, Bae S, Segev DL, Brennan DC, Alhamad T, Ouseph R, Lam NN, Nazzal M, Randall H, Kasiske BL, McAdams-Demarco M, Lentine KL.

Transpl Int. 2018 Feb;31(2):198-211. doi: 10.1111/tri.13079. Epub 2017 Nov 2.

22.

Effects of recurrent urinary tract infections on graft and patient outcomes after kidney transplantation.

Britt NS, Hagopian JC, Brennan DC, Pottebaum AA, Santos CAQ, Gharabagi A, Horwedel TA.

Nephrol Dial Transplant. 2017 Oct 1;32(10):1758-1766. doi: 10.1093/ndt/gfx237.

PMID:
28967964
23.

Quantitative Evaluation of the Impact of Ethylenediaminetetraacetic Acid Pretreatment on Single-Antigen Bead Assay.

Liu C, Pang S, Phelan D, Brennan DC, Mohanakumar T.

Transplant Direct. 2017 Jul 11;3(8):e194. doi: 10.1097/TXD.0000000000000709. eCollection 2017 Aug.

24.

Antidepressant medication use before and after kidney transplant: implications for outcomes - a retrospective study.

Lentine KL, Naik AS, Ouseph R, Zhang Z, Axelrod DA, Segev DL, Dharnidharka VR, Brennan DC, Randall H, Gadi R, Lam NN, Hess GP, Kasiske BL, Schnitzler MA.

Transpl Int. 2018 Jan;31(1):20-31. doi: 10.1111/tri.13006. Epub 2017 Aug 3.

25.

Mixed Donor Chimerism Following Simultaneous Pancreas-Kidney Transplant.

Rashidi A, Brennan DC, Amarillo IE, Wellen JR, Cashen A.

Exp Clin Transplant. 2018 Jun;16(3):307-313. doi: 10.6002/ect.2016.0299. Epub 2017 Jun 28. Review.

26.

Targeting High Calcineurin Inhibitor Levels After Acute Rejection With Less Tremor: A New Strategy.

Alhamad T, Venkatachalam K, Daloul R, Brennan DC, Malone AF.

Transplantation. 2017 Aug;101(8):e287-e288. doi: 10.1097/TP.0000000000001797. No abstract available.

PMID:
28422926
27.

Singing a New SONG: Outcomes for Clinical Trials.

Malone AF, Brennan DC.

Transplantation. 2017 Aug;101(8):1748-1750. doi: 10.1097/TP.0000000000001775. No abstract available.

PMID:
28403129
28.

The Privilege of Induction Avoidance and Calcineurin Inhibitors Withdrawal in 2 Haplotype HLA Matched White Kidney Transplantation.

Brifkani Z, Brennan DC, Lentine KL, Horwedel TA, Malone AF, Delos Santos R, Maw TT, Alhamad T.

Transplant Direct. 2017 Feb 8;3(3):e133. doi: 10.1097/TXD.0000000000000645. eCollection 2017 Mar.

29.

Cell-Free DNA and Active Rejection in Kidney Allografts.

Bloom RD, Bromberg JS, Poggio ED, Bunnapradist S, Langone AJ, Sood P, Matas AJ, Mehta S, Mannon RB, Sharfuddin A, Fischbach B, Narayanan M, Jordan SC, Cohen D, Weir MR, Hiller D, Prasad P, Woodward RN, Grskovic M, Sninsky JJ, Yee JP, Brennan DC; Circulating Donor-Derived Cell-Free DNA in Blood for Diagnosing Active Rejection in Kidney Transplant Recipients (DART) Study Investigators.

J Am Soc Nephrol. 2017 Jul;28(7):2221-2232. doi: 10.1681/ASN.2016091034. Epub 2017 Mar 9.

30.

Complete Genome Sequence of BK Polyomavirus Subtype Ib-1 Detected in a Kidney Transplant Patient with BK Viremia Using Shotgun Sequencing.

Ranjan R, Rani A, Brennan DC, Finn PW, Perkins DL.

Genome Announc. 2017 Feb 9;5(6). pii: e01474-16. doi: 10.1128/genomeA.01474-16.

31.

Transplant Center Volume and the Risk of Pancreas Allograft Failure.

Alhamad T, Malone AF, Brennan DC, Stratta RJ, Chang SH, Wellen JR, Horwedel TA, Lentine KL.

Transplantation. 2017 Nov;101(11):2757-2764. doi: 10.1097/TP.0000000000001628.

32.

Epstein-Barr virus and renal transplantation.

Le J, Durand CM, Agha I, Brennan DC.

Transplant Rev (Orlando). 2017 Jan;31(1):55-60. doi: 10.1016/j.trre.2016.12.001. Epub 2016 Dec 29. Review.

PMID:
28089555
33.

Letermovir for the management of cytomegalovirus infection.

Bowman LJ, Melaragno JI, Brennan DC.

Expert Opin Investig Drugs. 2017 Feb;26(2):235-241. doi: 10.1080/13543784.2017.1274733. Epub 2016 Dec 28. Review.

PMID:
27998189
34.

Ureteral stent placement and immediate graft function are associated with increased risk of BK viremia in the first year after kidney transplantation.

Maliakkal JG, Brennan DC, Goss C, Horwedel TA, Chen H, Fong DK, Agarwal N, Zheng J, Schechtman KB, Dharnidharka VR.

Transpl Int. 2017 Feb;30(2):153-161. doi: 10.1111/tri.12888. Epub 2016 Dec 28.

35.

Polyomavirus Reactivation and Immune Responses to Kidney-Specific Self-Antigens in Transplantation.

Seifert ME, Gunasekaran M, Horwedel TA, Daloul R, Storch GA, Mohanakumar T, Brennan DC.

J Am Soc Nephrol. 2017 Apr;28(4):1314-1325. doi: 10.1681/ASN.2016030285. Epub 2016 Nov 7.

36.

Differential risks for adverse outcomes 3 years after kidney transplantation based on initial immunosuppression regimen: a national study.

Dharnidharka VR, Schnitzler MA, Chen J, Brennan DC, Axelrod D, Segev DL, Schechtman KB, Zheng J, Lentine KL.

Transpl Int. 2016 Nov;29(11):1226-1236. doi: 10.1111/tri.12850. Epub 2016 Sep 28.

37.

A Snapshot of Antibody-Mediated Rejection Goes Viral.

Lim ES, Brennan DC.

Transplantation. 2017 Feb;101(2):227. doi: 10.1097/TP.0000000000001540. No abstract available.

PMID:
27779575
38.

Introduction: Kidney Transplantation and Viral Infection.

Brennan DC.

Semin Nephrol. 2016 Sep;36(5):343. doi: 10.1016/j.semnephrol.2016.05.010. No abstract available.

PMID:
27772618
39.

Urinary microbiome of kidney transplant patients reveals dysbiosis with potential for antibiotic resistance.

Rani A, Ranjan R, McGee HS, Andropolis KE, Panchal DV, Hajjiri Z, Brennan DC, Finn PW, Perkins DL.

Transl Res. 2017 Mar;181:59-70. doi: 10.1016/j.trsl.2016.08.008. Epub 2016 Sep 9.

40.

A diverse virome in kidney transplant patients contains multiple viral subtypes with distinct polymorphisms.

Rani A, Ranjan R, McGee HS, Metwally A, Hajjiri Z, Brennan DC, Finn PW, Perkins DL.

Sci Rep. 2016 Sep 16;6:33327. doi: 10.1038/srep33327.

41.

Predonation Prescription Opioid Use: A Novel Risk Factor for Readmission After Living Kidney Donation.

Lentine KL, Lam NN, Schnitzler MA, Hess GP, Kasiske BL, Xiao H, Axelrod D, Garg AX, Schold JD, Randall H, Dzebisashvili N, Brennan DC, Segev DL.

Am J Transplant. 2017 Mar;17(3):744-753. doi: 10.1111/ajt.14033. Epub 2016 Oct 13.

42.

The Changing Financial Landscape of Renal Transplant Practice: A National Cohort Analysis.

Axelrod DA, Schnitzler MA, Xiao H, Naik AS, Segev DL, Dharnidharka VR, Brennan DC, Lentine KL.

Am J Transplant. 2017 Feb;17(2):377-389. doi: 10.1111/ajt.14018. Epub 2016 Oct 4.

43.

Clinical and Economic Consequences of Early Cancer After Kidney Transplantation in Contemporary Practice.

Dharnidharka VR, Naik AS, Axelrod D, Schnitzler MA, Xiao H, Brennan DC, Segev DL, Randall H, Chen J, Kasiske B, Lentine KL.

Transplantation. 2017 Apr;101(4):858-866. doi: 10.1097/TP.0000000000001385.

44.

Diabetes Mellitus in Living Pancreas Donors: Use of Integrated National Registry and Pharmacy Claims Data to Characterize Donation-Related Health Outcomes.

Lam NN, Schnitzler MA, Segev DL, Hess GP, Kasiske BL, Randall HB, Axelrod D, Xiao H, Garg AX, Brennan DC, Lentine KL.

Transplantation. 2017 Jun;101(6):1276-1281. doi: 10.1097/TP.0000000000001375.

45.

Selected Mildly Obese Donors Can Be Used Safely in Simultaneous Pancreas and Kidney Transplantation.

Alhamad T, Malone AF, Lentine KL, Brennan DC, Wellen J, Chang SH, Chakkera HA.

Transplantation. 2017 Jun;101(6):1159-1166. doi: 10.1097/TP.0000000000001303.

PMID:
27428713
46.

Pretransplant Midodrine Use: A Newly Identified Risk Marker for Complications After Kidney Transplantation.

Alhamad T, Brennan DC, Brifkani Z, Xiao H, Schnitzler MA, Dharnidharka VR, Axelrod D, Segev DL, Lentine KL.

Transplantation. 2016 May;100(5):1086-93. doi: 10.1097/TP.0000000000001113.

47.

Pneumococcal 13-Valent Conjugate Vaccine (Prevnar 13)-Associated Immune Thrombocytopenic Purpura in a Renal Transplant Recipient: A Case Report.

Gupta S, Brennan DC.

Transplant Proc. 2016 Jan-Feb;48(1):262-4. doi: 10.1016/j.transproceed.2015.12.004.

PMID:
26915880
48.

Variation in Comedication Use According to Kidney Transplant Immunosuppressive Regimens: Application of Integrated Registry and Pharmacy Claims Data.

Lentine KL, Naik AS, Schnitzler M, Axelrod D, Chen J, Brennan DC, Segev DL, Kasiske BL, Randall H, Dharnidharka VR.

Transplant Proc. 2016 Jan-Feb;48(1):55-8. doi: 10.1016/j.transproceed.2015.12.024.

49.

National Variation in Use of Immunosuppression for Kidney Transplantation: A Call for Evidence-Based Regimen Selection.

Axelrod DA, Naik AS, Schnitzler MA, Segev DL, Dharnidharka VR, Brennan DC, Bae S, Chen J, Massie A, Lentine KL.

Am J Transplant. 2016 Aug;16(8):2453-62. doi: 10.1111/ajt.13758. Epub 2016 Mar 31.

50.

Pharmacoepidemiology of cytomegalovirus prophylaxis in a large retrospective cohort of kidney transplant recipients with Medicare Part D coverage.

Santos CA, Brennan DC, Saeed MJ, Fraser VJ, Olsen MA.

Clin Transplant. 2016 Apr;30(4):435-44. doi: 10.1111/ctr.12706. Epub 2016 Mar 4.

Supplemental Content

Loading ...
Support Center